Hennion & Walsh Asset Management, Inc. Iovance Biotherapeutics, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 499,252 shares of IOVA stock, worth $1.12 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
499,252
Previous 366,775
36.12%
Holding current value
$1.12 Million
Previous $1.31 Million
34.25%
% of portfolio
0.04%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding IOVA
# of Institutions
293Shares Held
234MCall Options Held
1.14MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$64.9 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$56.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$47.5 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$26.5 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.2 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $353M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...